SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-354945
Filing Date
2015-10-28
Accepted
2015-10-27 17:37:30
Documents
2
Group Members
ANDREW G. BLUHMDSC ADVISORS, L.L.C.DSC ADVISORS, L.P.DSC MANAGERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G d34238dsc13g.htm SC 13G 84333
2 EX-99.1 d34238dex991.htm EX-99.1 8320
  Complete submission text file 0001193125-15-354945.txt   94352
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Subject) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88808 | Film No.: 151178650
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611
Business Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611 312-915-2886
Delaware Street Capital Master Fund, L.P. (Filed by) CIK: 0001648576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G